ADIA’s India Equity Portfolio: 7% FY26 Gain & Stock Performance Review

Abu Dhabi Investment Authority (ADIA), the sovereign wealth fund of the United Arab Emirates, has seen a modest 7% gain in its Indian equity portfolio so far in fiscal year 2026. The portfolio, valued at approximately Rs 3,910 crore as of March 20, 2026, has grown from Rs 3,774 crore in March 2025. Even as the overall trend is positive, performance across individual holdings has been markedly uneven, with significant divergence between winners and laggards. This activity, tracked by ACE Equity and Trendlyne, offers a snapshot of ADIA’s evolving investment strategy within the Indian market.

Portfolio Performance: A Tale of Two Sides

As of December 2025, ADIA’s Indian equity holdings encompassed 26 publicly listed companies. Six of these stocks have experienced substantial gains, ranging from 30% to an impressive 110% during FY26 to date. Though, the majority of the portfolio has delivered negative returns and the four worst-performing stocks have declined between 30% and 47% over the same period. This disparity highlights the selective nature of ADIA’s success within the Indian market and the inherent risks associated with individual stock picking.

ADIA, established in 1976, manages the excess oil reserves of Abu Dhabi and is one of the world’s largest sovereign wealth funds, with an estimated $1.057 trillion in assets under management (AUM) as of late 2025, according to Wikipedia. The fund’s investment approach is generally characterized as long-term and diversified, though its operations have historically been described as opaque.

New Additions and Sector Shifts

During the December 2025 quarter, ADIA added three new stocks to its Indian portfolio: Strides Pharma, Indigo Paints, and Tenneco Clean Air. These additions suggest a potential shift in investment focus, with Strides Pharma representing the pharmaceutical sector, Indigo Paints targeting the consumer discretionary space, and Tenneco Clean Air indicating interest in the automotive component industry. The rationale behind these specific choices isn’t publicly detailed, but they reflect a broader trend of sovereign wealth funds seeking opportunities in emerging markets like India.

Strides Pharma Science Ltd., for example, is a global pharmaceutical company that develops and manufactures pharmaceutical products. Their website details their focus on emerging markets and complex generics. Indigo Paints, as the name suggests, is a relatively new player in the Indian paints industry, known for its innovative products and strong branding. Tenneco Clean Air, a subsidiary of Tenneco Inc., focuses on emission control technologies for vehicles.

The Broader Context of Sovereign Wealth Fund Investment in India

India has become an increasingly attractive destination for sovereign wealth funds due to its strong economic growth potential, favorable demographics, and ongoing reforms. The country’s stock market has as well performed well in recent years, offering attractive returns for foreign investors. However, investing in India also comes with its own set of challenges, including regulatory complexities, infrastructure bottlenecks, and political risks.

Other sovereign wealth funds active in India include the Government of Singapore Investment Corporation (GIC) and the Public Investment Fund (PIF) of Saudi Arabia. These funds typically invest in a range of asset classes, including equities, bonds, real estate, and infrastructure. Their investments often focus on long-term growth opportunities and strategic partnerships with Indian companies.

Implications for Indian Companies and Investors

ADIA’s investment activity in India has several implications for Indian companies and investors. The fund’s presence provides a significant source of capital for Indian businesses, helping them to fund their growth plans and expand their operations. It also lends credibility to the Indian market, attracting other foreign investors. However, the fund’s large size and long-term investment horizon can also create volatility in the market, as its buying and selling decisions can have a significant impact on stock prices.

For individual investors, ADIA’s activity can provide valuable insights into the attractiveness of different Indian companies and sectors. By tracking the fund’s investment decisions, investors can gain a better understanding of which companies are likely to perform well in the future. However, it’s important to remember that ADIA’s investment strategy is based on its own unique objectives and risk tolerance, and may not be suitable for all investors.

Navigating Risks and Future Outlook

The uneven performance within ADIA’s Indian portfolio underscores the inherent risks of equity investing, even for sophisticated institutional investors. Macroeconomic factors, such as inflation, interest rates, and global economic growth, can all impact stock prices. Company-specific risks, such as poor management, competitive pressures, and regulatory changes, can also lead to losses.

Looking ahead, ADIA is likely to continue investing in India, but its approach may become more selective. The fund will likely focus on companies with strong fundamentals, sustainable growth prospects, and attractive valuations. It may also increase its allocation to sectors that are expected to benefit from India’s economic growth, such as technology, healthcare, and consumer discretionary. The fund’s long-term commitment to the Indian market suggests a continued, albeit carefully considered, presence in the years to come.

What to watch: Regulatory filings from ADIA and updates from ACE Equity and Trendlyne will provide further insight into the fund’s evolving investment strategy and portfolio performance in the coming quarters. Monitoring the performance of the three newly added stocks – Strides Pharma, Indigo Paints, and Tenneco Clean Air – will be particularly informative.